Beijing Beilu Pharmaceutical Co., Ltd. (SHE:300016)

SHE:300016 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	304.98	257.46	748.45	766.73	895.02	1,014
Trading Asset Securities	396	350.77	-	-	-	-
Cash & Short-Term Investments	700.97	608.23	748.45	766.73	895.02	1,014
Cash Growth	-6.58%	-18.73%	-2.38%	-14.33%	-11.71%	308.10%
Accounts Receivable	217.85	176.36	188.55	112.67	142.52	190.37
Other Receivables	4.3	9.54	5.87	8.39	5.81	15.36
Receivables	222.15	185.9	194.42	121.06	148.33	205.73
Inventory	375.2	362.09	244.86	276.22	250.01	117.12
Other Current Assets	28.2	14.95	9.07	14	12.72	14.48
Total Current Assets	1,327	1,171	1,197	1,178	1,306	1,351
Property, Plant & Equipment	1,017	976.03	876.23	840.46	795.3	739.48
Long-Term Investments	523.63	536.76	556.06	561.19	553.2	508.43
Goodwill	46.92	46.92	-	31.82	51.23	51.23
Other Intangible Assets	154.71	160.82	128.39	125.1	138.99	138.04
Long-Term Accounts Receivable	1.46	1.43	-	-	-	-
Long-Term Deferred Tax Assets	40.66	41.33	41.38	39.32	18.15	11.07
Long-Term Deferred Charges	22.88	24.94	17.2	36.95	32.4	36.17
Other Long-Term Assets	61.81	18.11	3.38	5.83	8.92	12.1
Total Assets	3,196	2,978	2,819	2,819	2,904	2,848
Accounts Payable	185.19	171.32	115.12	140.9	141.13	137.03
Accrued Expenses	49.62	44.5	34.89	32.05	26.06	24.12
Short-Term Debt	160.02	140.02	175.56	107.61	79.08	143.91
Current Portion of Long-Term Debt	134.35	49	12.4	10.09	20.13	6
Current Portion of Leases	5.43	3.26	3.04	2.74	0.27	-
Current Income Taxes Payable	5.26	-	-	-	0.01	0.01
Current Unearned Revenue	8.18	8.76	2.01	4.45	3.8	7.95
Other Current Liabilities	35.44	38.38	16.14	4.83	15.09	24.54
Total Current Liabilities	583.5	455.23	359.17	302.67	285.56	343.54
Long-Term Debt	658.01	600.24	592.55	516.28	476.1	553.18
Long-Term Leases	1.94	4.8	7.17	9.98	0.14	-
Long-Term Unearned Revenue	27.04	16.84	11.74	7.89	10.45	13.76
Long-Term Deferred Tax Liabilities	66.88	70.93	62.48	58.56	45.98	45.01
Total Liabilities	1,337	1,148	1,033	895.39	818.22	955.5
Common Stock	495.21	491.95	491.93	491.96	492.72	494.49
Additional Paid-In Capital	161.88	135.34	135.22	135.3	201.27	188.53
Retained Earnings	931.82	926.45	912.79	1,019	1,042	945.96
Treasury Stock	-	-	-	-0.1	-9.06	-18.01
Comprehensive Income & Other	109.94	113.86	110.67	130.27	130.04	130.93
Total Common Equity	1,699	1,668	1,651	1,776	1,857	1,742
Minority Interest	159.44	161.9	135.69	146.88	229.03	150.17
Shareholders' Equity	1,858	1,829	1,786	1,923	2,086	1,892
Total Liabilities & Equity	3,196	2,978	2,819	2,819	2,904	2,848
Total Debt	959.75	797.32	790.72	646.71	575.72	703.09
Net Cash (Debt)	-258.78	-189.09	-42.28	120.03	319.31	310.64
Net Cash Growth	-	-	-	-62.41%	2.79%	25.05%
Net Cash Per Share	-0.56	-0.42	-0.09	0.21	0.66	0.64
Filing Date Shares Outstanding	495.21	491.95	491.93	491.96	492.72	494.49
Total Common Shares Outstanding	495.21	491.95	491.93	491.96	492.72	494.49
Working Capital	743.03	715.95	837.62	875.34	1,021	1,008
Book Value Per Share	3.43	3.39	3.36	3.61	3.77	3.52
Tangible Book Value	1,497	1,460	1,522	1,619	1,667	1,553
Tangible Book Value Per Share	3.02	2.97	3.09	3.29	3.38	3.14
Buildings	700.49	700.49	561.7	557.21	532.04	503.45
Machinery	591.64	567.37	503.01	470.31	400.02	288.48
Construction In Progress	129.92	70.26	110.39	44.99	49	87.3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.